Dr. Douglas Allen Swartz, MD

Dr. Swartz practices at Florida Physician Specialists in Jacksonville, Florida.

Dr. Swartz's NPI, 1144361908, was assigned on February 12, 2007. Dr. Swartz graduated from McGovern Medical School in 1979. Dr. Swartz holds Florida license ME46606.

Dr. Swartz's primary practice is Florida Physician Specialists, at 7017 A C Skinner Pkwy, Jacksonville, FL 32256 in Duval County. The practice phone is (904) 520-6800.

Dr. Swartz's primary practice is Florida Physician Specialists in Jacksonville, Florida. Dr. Swartz is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Florida Physician Specialists. Dmand AI also links Dr. Swartz to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Swartz practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Swartz's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Swartz is board certified in urology by the American Board of Urology. Dmand AI has Dr. Swartz's licenses on file in 2 states: Florida and Texas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Swartz treats.

CMS data shows 11,622 Medicare services from Dr. Swartz across 26 procedure codes in 2024, for 841 Medicare patients. Medicare paid $393,027 for them.

CMS counts 841 Medicare patients who saw Dr. Swartz in 2024. The largest group is 75 to 84, with 411 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Swartz's median patient age at 73, with 11% women.

In 2024, Dr. Swartz wrote 3,724 Medicare Part D claims for 782 patients. 87% of them were for generic drugs. CMS names the drug for 3,464 of them, across 46 drugs with 11 or more claims each, at $3,346,791 in total drug cost. In 2023, CMS named 3,447 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Swartz for performance year 2024, reported individually. Dr. Swartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Swartz as offering telehealth. CMS counts 21 procedures of prostate resection by Dr. Swartz, more than 83% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Swartz, published from 2012 to 2019. 2019 was the busiest year, with 2. The most frequent topics are Brachytherapy, Prostatic Neoplasms and Urinary Bladder Neoplasms. Dr. Swartz has published most often in Brachytherapy. Dr. Swartz's most frequent co-authors are Jamie A. Cesaretti, MD, Mitchell D. Terk, MD and Apoorva R. Vashi, MD.

CMS Open Payments shows 228 general payments to Dr. Swartz from 45 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 91% of the total. SRS Medical Systems, Inc. paid the most, $139,542.

Dmand AI lists 3 awards for Dr. Swartz, most recently Top Doctors: Florida in 2000.

Dr. Swartz graduated from McGovern Medical School in 1979. Dr. Swartz is a member of ACS.

Dr. Swartz is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.